Last data update: Sep 28, 2021. (Total: 3497 publications since 2011)
|Query Trace: all>>Beverly Metchock[CDC Author]|
| Towards Unified Data Exchange Formats for Reporting Molecular Drug Susceptibility Testing.
Wilfred Bonney, Sandy F Price, , Swapna Abhyankar, Riki Merrick, Varsha Hampole, Tanya A Halse, Charles DiDonato, Tracy Dalton, Beverly Metchock, Angela M Starks, and Roque Miramontes
Online journal of public health informatics 2020 12(2) e14
Similar articles in PubMed DOI:10.5210/ojphi.v12i2.10644
| Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
Justin L Kandler, Alexandra D Mercante, Tracy L Dalton, Matthew N Ezewudo, Lauren S Cowan, Scott P Burns, Beverly Metchock, , Peter Cegielski, and James E Posey
Antimicrobial agents and chemotherapy 2018 Aug
Similar articles in PubMed DOI:10.1128/AAC.00974-18
| Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States.
Mitchell A Yakrus, Jeffrey Driscoll, Allison McAlister, David Sikes, Denise Hartline, Beverly Metchock, and Angela M Starks
Tuberculosis research and treatment 2016 3404860
Similar articles in PubMed DOI:10.1155/2016/3404860
| Evaluation of a u.s. Public health laboratory service for the molecular detection of drug resistant tuberculosis.
Mitchell A Yakrus, Beverly Metchock, and Angela M Starks
Tuberc Res Treat 2015 701786
Similar articles in PubMed DOI:10.1155/2015/701786
| DNA sequencing for confirmation of rifampin resistance detected by Cepheid Xpert MTB/RIF assay.
Allison J McAlister, Jeffrey Driscoll, and Beverly Metchock
J. Clin. Microbiol. 2015 May 53(5) 1752-3
Similar articles in PubMed DOI:10.1128/JCM.03433-14
| Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States.
Mitchell A Yakrus, Jeffrey Driscoll, Allison J Lentz, David Sikes, Denise Hartline, Beverly Metchock, and Angela M Starks
J. Clin. Microbiol. 2014 Jun 52(6) 1932-7
Similar articles in PubMed DOI:10.1128/JCM.00417-14
| Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Patricia J Campbell, Glenn P Morlock, R David Sikes, Tracy L Dalton, Beverly Metchock, Angela M Starks, Delaina P Hooks, Lauren S Cowan, Bonnie B Plikaytis, and James E Posey
Antimicrobial agents and chemotherapy 2011 May 55(5) 2032-41
Similar articles in PubMed DOI:10.1128/AAC.01550-10